• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希腊年龄相关性黄斑变性的患病率:塞萨洛尼基眼病研究

Prevalence of age-related macular degeneration in Greece: the Thessaloniki Eye Study.

作者信息

Topouzis Fotis, Coleman Anne L, Harris Alon, Anastasopoulos Eleftherios, Yu Fei, Koskosas Archimidis, Pappas Theofanis, Mavroudis Leonidas, Wilson M Roy

机构信息

II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.

出版信息

Am J Ophthalmol. 2006 Dec;142(6):1076-9. doi: 10.1016/j.ajo.2006.07.042. Epub 2006 Sep 5.

DOI:10.1016/j.ajo.2006.07.042
PMID:17157601
Abstract

PURPOSE

To estimate the age- and gender-specific prevalence of age-related macular degeneration (AMD) in a population-based sample of subjects 60 years of age or older in Thessaloniki, Greece.

DESIGN

Cross-sectional population-based study.

METHODS

A total of 2554 subjects randomly identified from municipality registers in Thessaloniki underwent a complete ophthalmologic examination.

RESULTS

Of the 3617 eligible subjects, 2554 (71%) participants completed a clinical examination. The prevalence was 2.5% for AMD, 1.4% for neovascular (NV) AMD, and 1.3% for geographic atrophy (GA). Bilateral AMD was present in 40% of AMD cases. The prevalence of AMD, NV, GA, and bilateral AMD increased with increasing age (P< .0001). No gender-specific statistically significant differences were noted. Of all participants with AMD, 67% were unaware of the diagnosis.

CONCLUSIONS

The prevalence of AMD in Greece is comparable to that in other Caucasian populations. A dramatic increase in prevalence in people older than 80 years of age was observed.

摘要

目的

在希腊塞萨洛尼基以人群为基础的60岁及以上受试者样本中,评估年龄相关性黄斑变性(AMD)的年龄和性别特异性患病率。

设计

基于人群的横断面研究。

方法

从塞萨洛尼基市登记册中随机抽取的2554名受试者接受了全面的眼科检查。

结果

在3617名符合条件的受试者中,2554名(71%)参与者完成了临床检查。AMD的患病率为2.5%,新生血管性(NV)AMD为1.4%,地图样萎缩(GA)为1.3%。40%的AMD病例存在双侧AMD。AMD、NV、GA和双侧AMD的患病率随年龄增长而增加(P<0.0001)。未发现性别特异性的统计学显著差异。在所有患有AMD的参与者中,67%未意识到自己的诊断。

结论

希腊AMD的患病率与其他白种人群相当。观察到80岁以上人群的患病率急剧上升。

相似文献

1
Prevalence of age-related macular degeneration in Greece: the Thessaloniki Eye Study.希腊年龄相关性黄斑变性的患病率:塞萨洛尼基眼病研究
Am J Ophthalmol. 2006 Dec;142(6):1076-9. doi: 10.1016/j.ajo.2006.07.042. Epub 2006 Sep 5.
2
5-year incidence of age-related maculopathy in the Reykjavik Eye Study.雷克雅未克眼科研究中年龄相关性黄斑病变的5年发病率。
Ophthalmology. 2005 Jan;112(1):132-8. doi: 10.1016/j.ophtha.2004.07.020.
3
Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study.希腊开角型青光眼的患病率:塞萨洛尼基眼病研究
Am J Ophthalmol. 2007 Oct;144(4):511-9. doi: 10.1016/j.ajo.2007.06.029.
4
Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study.日本成年人群年龄相关性黄斑变性的患病率及危险因素:船形田研究
Ophthalmology. 2008 Aug;115(8):1376-81, 1381.e1-2. doi: 10.1016/j.ophtha.2007.11.015. Epub 2008 Jan 25.
5
Cigarette smoking and age-related macular degeneration in the EUREYE Study.欧洲眼研究中吸烟与年龄相关性黄斑变性
Ophthalmology. 2007 Jun;114(6):1157-63. doi: 10.1016/j.ophtha.2006.09.022. Epub 2007 Mar 6.
6
Risk factors for age-related macular degeneration: findings from the Andhra Pradesh eye disease study in South India.年龄相关性黄斑变性的危险因素:来自印度南部安得拉邦眼病研究的结果。
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4442-9. doi: 10.1167/iovs.05-0853.
7
Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes.韩国筛查人群中的年龄相关性黄斑变性:患病率、危险因素及亚型
Ophthalmic Epidemiol. 2009 Sep-Oct;16(5):304-10.
8
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.年龄相关性黄斑变性的15年累积发病率:比弗迪尔姆眼科研究
Ophthalmology. 2007 Feb;114(2):253-62. doi: 10.1016/j.ophtha.2006.10.040.
9
Comparison of comorbid conditions between neovascular age-related macular degeneration patients and a control cohort in the medicare population.医疗保险人群中新血管性年龄相关性黄斑变性患者与对照队列之间共病情况的比较。
Retina. 2007 Nov-Dec;27(9):1292-9. doi: 10.1097/01.iae.0000300915.81866.b8.
10
The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: the Oslo Macular study.挪威城市人群中年龄相关性黄斑病变(ARM)的患病率:奥斯陆黄斑研究
Acta Ophthalmol Scand. 2006 Oct;84(5):636-41. doi: 10.1111/j.1600-0420.2006.00696.x.

引用本文的文献

1
Inter- and intraobserver repeatability and reproducibility of choroidal thickness measurements using two different methods.使用两种不同方法测量脉络膜厚度时观察者间和观察者内的可重复性与再现性。
Int Ophthalmol. 2019 May;39(5):1061-1069. doi: 10.1007/s10792-018-0909-z. Epub 2018 Mar 31.
2
Treatment satisfaction of patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor agents.接受抗血管内皮生长因子药物治疗的新生血管性年龄相关性黄斑变性患者的治疗满意度
Int Ophthalmol. 2018 Apr;38(2):565-576. doi: 10.1007/s10792-017-0492-8. Epub 2017 Mar 11.
3
Reliability, validity and responsiveness of the Greek MacDQoL individualized measure of the impact of macular degeneration on quality of life.
希腊版黄斑变性对生活质量影响的MacDQoL个体化测量工具的信度、效度及反应度
Qual Life Res. 2017 Jan;26(1):183-191. doi: 10.1007/s11136-016-1407-2. Epub 2016 Sep 10.
4
The Prevalence of Age-Related Eye Diseases and Cataract Surgery among Older Adults in the City of Lodz, Poland.波兰罗兹市老年人中年龄相关性眼病及白内障手术的患病率
J Ophthalmol. 2015;2015:605814. doi: 10.1155/2015/605814. Epub 2015 Feb 19.
5
The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence.年龄相关性黄斑变性治疗药物的药物经济学评价质量:系统评价和证据定量评估。
Br J Ophthalmol. 2010 Sep;94(9):1118-26. doi: 10.1136/bjo.2009.170282.
6
The Minnesota Grading System using fundus autofluorescence of eye bank eyes: a correlation to age-related macular degeneration (an AOS thesis).使用眼库眼的眼底自发荧光的明尼苏达分级系统:与年龄相关性黄斑变性的相关性(一篇美国眼科学会论文)
Trans Am Ophthalmol Soc. 2008;106:383-401.
7
Age-related macular degeneration and the aging eye.年龄相关性黄斑变性与老年眼
Clin Interv Aging. 2008;3(3):473-82. doi: 10.2147/cia.s2777.